Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Expertise in exosomes isolation and characterization will drive innovation in this field
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Cipla has reported consolidated financial results for the period ended September 30, 2021
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Subscribe To Our Newsletter & Stay Updated